01 6Neupro
02 9Neupro Patch
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 348
2018 Revenue in Millions : 350
Growth (%) : -1
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 123
2019 Revenue in Millions : 127
Growth (%) : -3
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 376
2019 Revenue in Millions : 386
Growth (%) : -3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 97
2020 Revenue in Millions : 118
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 338
2020 Revenue in Millions : 376
Growth (%) : -1
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 75
2021 Revenue in Millions : 97
Growth (%) : -23
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 325
2021 Revenue in Millions : 338
Growth (%) : -4
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 302
2022 Revenue in Millions : 325
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 57
2022 Revenue in Millions : 75
Growth (%) : -13
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 48
2023 Revenue in Millions : 57
Growth (%) : -17
